Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer

Cytometry

Volumn 32, Issue 2, 1998, Pages 109-119

  Healy, Cynthia G ^a   Simons, Jonathan W ^b   Carducci, Michael A ^b   DeWeese, Theodore L ^b   Bartkowski, Michelle ^b   Tong, Kim P ^b   Bolton, Wade E ^a  

^a BECKMAN COULTER INC   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Prostate cancer; Signal transduction; TCR; Zeta

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYCLINE; INTERLEUKIN 2 RECEPTOR; RECEPTOR SUBUNIT; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA; HUMANS; KILLER CELLS, NATURAL; MALE; MEMBRANE PROTEINS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; REFERENCE VALUES; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0032102948     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G     Document Type: Article

References (58)

1. Altman A, Mustelin T, Coggeshall K: T lymphocyte activation: A biological model of signal transduction. Grit Rev Immunol 10:347-391, 1990.
2. Anderson P, Blue M-L, O'Brien C, Schlossman S: Monoclonal antibodies reactive with the T cell receptor ζ chain: Production and characterization using a new method. J Immunol 143:1899-1904, 1989.
3. Anderson P, Caliguiri M, Ritz J, Schlossman S: CD3-negative natural killer cells express ζ, TCR as part of a novel molecular complex. Nature 341:159-162, 1989
4. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman S: Fey receptor type III (CD 16) is included in the ζ NK receptor complex expressed by human natural killer cells, Proc Natl Acad Sci USA 87:2274-2278, 1990.
5. Arpaia E, Shahar M, Dadi H, Cohen U, Roilman CM: Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase. Cell 76:947-958, 1994.
6. Baeuerle PA, Henkel T: Function and activation of NFκB in the immune system. Annu Rev Immunol 12:141-149, 1994.
7. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler L, Freeman G, Glimcher L: Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90:5687-5690, 1993.
8. Berns AJM, Clift S, Cohen LK, Donehower RC, Dranoff G, Handa KM, Jaffee E, Lazcnby A, Levitsky HI, Marshall FF, Mulligan RC, Nelson WG, Owens AH Jr, Pardoll DM, Parry G, Partin AH, Piantados S, Simons JW, Zabora, JR: Phase I study of non-replicating autologous tumor cell injections using cells prepared with and without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum Gene Ther 6:347-368, 1995.
9. Bolton W, Maples J, Siiman O, Kenyon N, Healy CG: Anti-CD3 antibody-aminodextran conjugates for induction of T cell activation and proliferation. U S Patent No 5,527,713, issued 18 Jim 1996.
10. Bonifacino JS, Chen C, Lippincott-Schwartz J, Ashwell JD, Klausner RD: Subunit interactions within the T cell antigen receptor: Clues from the study of partial complexes. Proc Natl Acad Sci USA 85:6929-6931, 1988.
11. Broder S, Waldman T: The suppressor-cell network in cancer. N EngI J Med 299:1335-1341, 1978.
12. Browning MJ, Bodmer WF: MHC antigens and cancer: Implications for T cell surveillance. Curr Opinion Immunol 4:613-618, 1992.
13. Carducci MA, Ayyagari SR, Sanda MG. Simons JW: Gene therapy for human prostate cancer. Cancer 75: 2013-2020, 1995.
14. Chan AC, Irving BA, Fraser JD, Weiss A: The ζ chain is associated with the tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 88:9166-9170, 1991.
15. Columbo M, Forni G: Cytokine gene transfer in tumor inhibition and tumor therapy: Where are we now? Immunol Today 15:48-51, 1994.
16. Crabtree G: Contingent genetic regulatory events in T lymphocyte activation. Science 243:355-361, 1989.
17. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K Jackson V, Hamada H, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting antitumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993.
18. Ebert E, Roberts A, O'Connell S, Robertson F, Nagase H: Characterization of an immunosuppressive factor derived from colon cancer cells. J Immunol 138:2161-2168, 1987.
19. Escudier B, Farace F, Angevin E, Triebel F, Antoun S, Leclerq B, Brandely M, Aboudaram A, Nitenberg G, Hercend T: Combination of Interleukin-2 and gamma Interferon in metastatic renal cell carcinoma. Eur J Cancer 29A:724-728, 1993.
20. Farace F, Angevin E, Vanderplanckc J, Escudier B. Triebel F: The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int J Cancer 59:752-755, 1994.
21. lck in T cells infiltrating human renal cell carcinoma. Cancer Res 53:5613-5616, 1993.
22. Franco J, Ghosh P, Wiltrout R, Carter C, Zea A, Momozaki N, Ochoa A : Partial degradation of T cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res 55:3840-3846, 1995.
23. Geller RL: Role of cross-linking in stepwise activation of T cells. Scand J Immunol 35:327-334, 1992.
24. Ghosh P, Komschlies K, Cippitelli M, Longo D, Subleski J, Ye J, Sica A, Young H, Wiltrout R, Ochoa A : Gradual loss of T-Helper 1 populations in spleen of mice during progressive tumor growth. J Natl Cancer Inst 87:1478-1483, 1995.
25. Hersh E, Oppenheim J: Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med 273:1006-1012, 1965.
26. Kono K, Ressing M, Brandt R, Melief C, Potkul R, Andersson B, Petersson M, Kast W, Kiessling R: Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2:1825-1828, 1996.
27. Lai P, Rabinowich H, Crowley-Nowick P, Bell M, Mantovani G, Whiteside, T: Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 2:161-173, 1996.
28. Loeffler CM, Smyth M, Longo D, Kopp W, Harvey H, Tribble J, Tasse W, Urba W. Leonard A, Young H, Ochoa A: Immunoregulation in cancer bearing hosts: Down regulation of gene expression and cytotoxic function in CD8+ T cells. J Immunol 149:949-956, 1992.
29. Matsuda M, Petersson M, Lenkei R, Taupin J-L, Magnusson I, Mellstedt H, Anderson P, Kiessling R: Alterations in the signal transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease. Int J Cancer 61:765-772, 1995.
30. Miescher S, Whiteside T, Carrel S, von Fliedner V: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899-1907, 1986.
31. Minami T, Kono T, Miyazaki T, Taniguchi T: The IL-2 receptor complex: Its function, and target genes. Annu Rev Immunol 11:245-268, 1993.
32. Mizoguchi H, O'Shea J, Longo D, Loeffler C, McVicar D, Ochoa A: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795-1798, 1992.
33. Mulligan RC: The basic science of gene therapy. Science 260:926-932, 1993.
34. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610-5612, 1993.
35. North RJ: Cyclophosphamide-facilitated adoptive immune therapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155:1063-1074, 1982.
36. + effector T cells. J Exp Med 159:1295-1311, 1983
37. Ostrand-Rosenberg S, Thakur A, Clements V : Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol 144:4068-4071, 1990.
38. Pardoll DM: Cancer vaccines. Immunol Today 14:310-316, 1993.
39. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. Cancer J Clin 46:5-28, 1996.
40. Roszman T, Elliott L, Brooks V: Modulation of T cell function by gliomas. Immunol Today 12:370-312, 1991.
41. Roth J, Osborne B, Ames R: Immuno regulatory factors derived from human tumors II Partial purification and further immunobiochemical characterization of a human sarcoma-derived immimosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. J Immunol 130:303-308, 1983.
42. Salvadori S, Gansbacher B, Pizzimenti A, Zier K: Abnormal signal transduction by T cells of mice with parental tumors in not seen in mice bearing IL-2 secreting tumors. J Immunol 153:5176-5182, 1994.
43. Samelson LE, Phillips AF, Luong ET, Klausnser RD: Association of the fyn protein tyrosine kinase with the T cell antigen receptor. Proc Natl Acad Sci USA 87:4358, 1990.
44. Sancho J, Peter ME, Franco R, Danielian S, Kang JS, Fagard R, Woods J, Reed JC, Kamoun M, Terhorst C: Coupling of GTP-binding to the T cell receptor (TCR) ζ-chain with TCR-Mediated signal transduction. J Immunol 150:3230-3242, 1993.
45. Sanda MG, Ayyagar SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151:622-628, 1994
46. Schwanz R: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065, 1992.
47. Sedlmayr P, Rabinowich H, Winlestein A, Herberman R, Whiteside T: Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukemia. Br J Cancer 65:222-228, 1992.
48. Sulizeanu D: Immunosuppressive factors in human cancers. Adv Cancer Res 60:247-267, 1993.
49. Tannock IF, Osoba D, Stockier MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wislon JJ, Vermer PM, Coppin CML, Murphy KC: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 14:1756-1764, 1996.
50. van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJ, Cornelisse CJ: Cell-cycle related staining patterns of anti-prolifcrating cell nuclear antigen monoclonal antibodies: Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol 138:1165-1172, 1991.
51. lck. Cell 5:301-307 1988.
52. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P: Expression and tyrosine phosphorylation of the T cell receptor ζ-subunit in human thymocytes. J Immunol 146:206-210, 1991.
53. Vogelzang NJ: One hundred thirteen men with hormone-refractory prostate cancer died today. J Clin Oncol 14:1753-1755, 1996.
54. Wallich R, Bulbuc N, Hammerling G, Katzav S, Segal S, Feldman M: Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 315:301-305, 1985.
55. Walsh PC, Partin AW, Epstein JI: Cancer control and quality of life following anatomical radical retropubtc prostatectomy: Results at 10 years. J Urol 152:1831-1836, 1994.
56. Weiss A, Littman, DR: Signal transduction by lymphocyte antigen receptors. Cell 76:263-274, 1994.
57. Zea A, Curti B, Longo D, Alvord W, Strobl S, Mizoguchi H, Creekmore S, O'Shea J, Powers G, Urba W, Ochoa A: Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1:1327-1335, 1995.
58. Zier K, Gansbacher B, Salvadori S: Preventing abnormalities in signal transduction of T cells in cancer: The promise of cytokine gene therapy. Immunol Today 17:39-45,1996.